Drugs / Inactivated hepatitis A vaccine
Inactivated hepatitis A vaccine
Trials 4 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 32 trials | ||||||
| Phase 3 | NCT06978621 | May → Jun 2025 overdue | hepatitis A virus infection | Chiang Mai University | Active not recruiting | No outcome recorded |
| Phase 3 | NCT03654664 | Jun 2017 → Jun 2019 | hepatitis A virus infection | Boryung Pharmaceutical Co., Ltd | Completed | No outcome recorded |
| Phase 42 trials | ||||||
| Phase 4 | NCT05526820 | Apr 2021 | chickenpox | Sinovac (Dalian) Vaccine Technology Co., Ltd. | Completed | No outcome recorded |
| Phase 4 | NCT02445703 | May 2014 → Jan 2015 | hepatitis A virus infection, hepatitis B virus infection | Sinovac Biotech Co., Ltd | Completed | No outcome recorded |
Also used as a comparator or background therapy in 3 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT01453348 Comparator | Oct 2011 → Jan 2012 | hepatitis A virus infection, hepatitis B virus infection, meningococcal meningitis | Novartis Vaccines | Completed | No outcome recorded |
| Phase 42 trials | ||||||
| Phase 4 | NCT04953325 Comparator | Jul → Oct 2021 | COVID-19 | Sinovac Research and Development Co., Ltd. | Completed | No outcome recorded |
| Phase 4 | NCT02526550 Background | Jun → Jul 2014 | encephalitis | Siriraj Hospital | Completed | No outcome recorded |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 8 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Inactivated hepatitis A vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03654664 ↗ |
| Known as | HAV | “Inactivated Hepatitis A vaccine (HAV)” NCT02445703 ↗ |
| Known as | HepA | “This study aimed to evaluate the immunogenicity and safety of co-administration with live attenuated varicella vaccine (VarV) and inactivated hepatitis A vaccine (HepA) among...” PMID 36593652 ↗ Jan 2023 |
| Known as | I-HAV | “inactivated vaccine (I-HAV, 2 doses)” NCT06978621 ↗ |
| Known as | inactivated HAV vaccine | “inactivated HAV vaccine (I-HAV) which is recommended as a 2-dose series administered 6 months apart” NCT06978621 ↗ |
| Modality | Vaccine | “Inactivated hepatitis A vaccine” NCT01453348 ↗ |
| Route | Intramuscular | “administered intramuscularly” NCT01453348 ↗ |